niCARdipine Hydrochloride Injection: recall status
Notice names this product. American Regent’s niCARdipine Hydrochloride Injection is named in FDA Class II recall D-0802-2026.
Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies.Agency-reported hazard: Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Identifying details: Lot #: 25295N0C0, Exp. Date: 04/30/2027.. Units affected: 43,460 vials. Status: Ongoing.
1. Compare your item
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Product named
niCARdipine Hydrochloride Injection
Company / brand
American Regent
Lot / serial / date codes
Lot #: 25295N0C0, Exp. Date: 04/30/2027.
Distribution
Nationwide within the U.S
Agency product description and boundaries
niCARdipine Hydrochloride Injection, USP, 25 mg/10mL (2.5 mg/mL), packaged in a) 10 mL Single Dose Vial (NDC 72572-470-01) and b) 10x10 mL Single Dose Vials (NDC 72572-470-10), Rx Only, Mfd for: Civica, Inc., Lehi, UT, Mfd by: American Regent, Inc., New Albany, OH 43054.
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.